Helicobacter pylori eradication as prevention against chronic peptic ulcer disease in children

E Maciorkowska1, M Kaczmarski, J Skowrońska

  • 1Department of Pediatric Nursing, Medical University of Białystok, Poland. emaciorkowska@o2.pl

Insights

Helicobacter pylori infection causes chronic gastritis in children, increasing the risk of gastric and duodenal ulcers in their families. Early detection and eradication are key for preventing peptic ulceration.

Area of Science:

  • Gastroenterology
  • Pediatric Medicine
  • Infectious Diseases

Background:

  • Helicobacter pylori infection causes a slow inflammatory process in the gastric mucosa.
  • This inflammation can lead to gastric and duodenal ulcers and, in some cases, gastric cancer.
  • Chronic gastritis in children warrants long-term observation due to potential family-wide implications.

Purpose of the Study:

  • To analyze morphological changes in the gastric mucosa of children with H. pylori IgG.
  • To evaluate the incidence of gastric and duodenal ulcers in family members of these children.
  • To assess the role of H. pylori in pediatric chronic gastritis and its familial impact.

Main Methods:

  • Analysis of gastric mucosa in children with positive H. pylori IgG.
  • Evaluation of ulcer incidence in families of pediatric patients.
  • Serological testing for H. pylori IgG antibodies.

Main Results:

  • Gastritis was present in 68.8% of children with H. pylori IgG.
  • Gastric ulcers were confirmed in 37.1% of families.
  • Duodenal ulcers were found in 22.9% of families.

Conclusions:

  • H. pylori-induced chronic gastritis in children necessitates long-term monitoring.
  • Considering H. pylori eradication is crucial for preventing peptic ulceration in affected families.
  • Early intervention in children can mitigate familial risk of ulcers.

Related Concept Videos

Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors01:24

Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors

Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI)  tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining. Bicarbonate,...
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors01:13

Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors

Peptic ulcers, often induced by H. pylori infections or NSAID usage, arise from disruptions in the delicate balance of gastric acid production. Peptic ulcers stem from heightened gastric acid levels due to H. pylori infections or NSAID use. The protective mucus layer diminishes in the presence of these factors, allowing gastric acid to erode the stomach lining and form ulcers.
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
Peptic Ulcer Disease IV: Management01:26

Peptic Ulcer Disease IV: Management

Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
Peptic Ulcer01:27

Peptic Ulcer

Peptic ulcers are erosive lesions of the gastric or duodenal lining, most commonly caused by Helicobacter pylori infection. This Gram-negative, helical bacterium has adapted to survive the stomach’s acidic environment by producing urease, which converts urea into ammonia and carbon dioxide. The ammonia neutralizes gastric acid in the bacterium’s immediate environment, allowing colonization of the gastric mucosa. H. pylori attaches to mucus-secreting epithelial cells, penetrates the mucus...
Peptic Ulcer Disease II: Pathophysiology01:24

Peptic Ulcer Disease II: Pathophysiology

Peptic ulcer disease develops when protective mechanisms of the gastrointestinal mucosa are overwhelmed by harmful factors, leading to localized erosions in the stomach or proximal duodenum. The main causes are Helicobacter pylori infection and chronic use of nonsteroidal anti-inflammatory drugs (NSAIDs).Helicobacter pylori–Induced InjuryBacterial Adaptation and Colonization:H. pylori is a spiral, Gram-negative bacterium adapted to the acidic stomach. and transmitted through oral-oral or...